KurCoSmart Effects on People With Type 2 DM

Sponsor
Universitas Sebelas Maret (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05407467
Collaborator
(none)
40
1
2
3
13.2

Study Details

Study Description

Brief Summary

The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and insulin resistance evaluation

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Curcumin and virgin coconut oil extract (KurCo Smart)
Phase 1/Phase 2

Detailed Description

The investigators give Kurcosmart supplementation aside from diabetes standard treatment to evaluate its benefits on people with type 2 DM, considering its effect on controlling fasting and prandial blood glucose, reducing HbA1c level, controlling inflammation degree; and repairing insulin resistance

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
KurCoSmart Effects on People With Type 2 DM: a Randomized, Open Trial
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

There is no additional intervention other than subject's standard diabetes treatment

Experimental: Interventional Group

This group will received additional supplementation of curcumin and virgin coconut oil aside from their standard treatment

Dietary Supplement: Curcumin and virgin coconut oil extract (KurCo Smart)
we give 2 tablets of curcumin and virgin coconut oil extract thrice a day for 30 days and evaluate the result

Outcome Measures

Primary Outcome Measures

  1. Blood glucose [Change of Blood glucose at 1 months]

    Subject's fasting and prandial blood glucose

  2. Inflammation degree [Change of hs-CRP at 1 Months]

    Subject's high sensitivity C-reactive protein level

  3. insulin resistance [Change of HOMA IR at 1 Months]

    Subject's HOMA IR

  4. HbA1c [Change of HbA1C at 1 Months]

    Subject's glycated haemoglobin level

Secondary Outcome Measures

  1. Body Mass Index [Change of BMI at 1 Months]

    Subject's height and body weight

  2. Blood Pressure [Change fof blood prssure at 1 Months]

    Subject's blood pressure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed Type 2 DM

  • Signing consent form

Exclusion Criteria:
  • Pregnant or breastfeeding

  • Multiple organ failure

  • History of hypersensitivity reaction to curcumin and virgin coconut oil

  • Cancer, renal insufficiency, hematological disease, acute heart failure, chronic liver disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 UNS Hospital Sukoharjo Central Java Indonesia 57161

Sponsors and Collaborators

  • Universitas Sebelas Maret

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nurhasan Agung Prabowo, M.D., Universitas Sebelas Maret
ClinicalTrials.gov Identifier:
NCT05407467
Other Study ID Numbers:
  • KurCoSmart
First Posted:
Jun 7, 2022
Last Update Posted:
Jun 7, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nurhasan Agung Prabowo, M.D., Universitas Sebelas Maret
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2022